Mon, Aug 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Swiss volatility arbitrage fund up 25% in 2012 by profiting from market's myopia

Tuesday, February 05, 2013

amb
Dr. Michel Dominice
Benedicte Gravrand, Opalesque Geneva:

The Cassiopeia Fund, a volatility arbitrage fund, was launched in 2003, after years of research done by the fund's founder, Dr. Michel Dominicé. This fund profit s from markets' irrational moves and proves through its performance that a rational approach to irrationality can lead to high reward.

Indeed, the Share Class B of the fund, which runs $689m, returned 25% in 2012, after annualising 15% since its August 2004 inception. The HFRX Volatility Index returned 9.7% in 2012, and the Lyxor Convertible Bonds & Volatility Arbitrage Index advanced 4.5%.

Run from the Geneva offices of Dominicé & Co, the Cassiopeia fund has kept a low profile over the years, until it won an award last year as the best Swiss single hedge fund. Cassiopeia was apparently also the only volatility trader to make Barron's 2011 top 100 Hedge Fund Survey, on which it ranked 49th. The firm is now moving up a gear in terms of visibility.

Statistically significant market bias

Dr. Dominicé, who studied political economy at the University of St. Gallen, had alwa......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Same day reporting and the evolving role of fund administrators[more]

    By: Scott Price, Head of Business Development and Client Management for North America, Maitland Ernst & Young’s latest glob

  2. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  3. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  4. Cowen Group, Inc. to acquire Conifer Securities[more]

    Cowen Group, Inc. and Conifer Securities, LLC had announced the signing of a definitive agreement under which Cowen will acquire Conifer Securities, the prime services division of Conifer Financial Services LLC. The transaction, the terms of which have not yet been disclosed, was approved by the boa

  5. Cargill’s Black River Asset to shut down four hedge funds[more]

    Komfie Manalo, Opalesque Asia: Cargill Inc.’s $7.4 billion Black River Asset Management said it was closing four hedge funds with a combined $ 1 billion in assets and start returning investors money over the next several months, various media said. The hedge funds represent 15% of Black River’

 

banner